000 | 01945 a2200493 4500 | ||
---|---|---|---|
005 | 20250514212645.0 | ||
264 | 0 | _c20050511 | |
008 | 200505s 0 0 eng d | ||
022 | _a0887-4476 | ||
024 | 7 |
_a10.1002/syn.20104 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Su-Jane | |
245 | 0 | 0 |
_aPotential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex. _h[electronic resource] |
260 |
_bSynapse (New York, N.Y.) _cMar 2005 |
||
300 |
_a156-63 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a4-Aminopyridine _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
650 | 0 | 4 |
_aCalcium Channels _xdrug effects |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 |
_aCyclic S-Oxides _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aFluoxetine _xpharmacology |
650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
650 | 0 | 4 |
_aIonomycin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xdrug effects |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMembrane Transport Proteins _xdrug effects |
650 | 0 | 4 |
_aNerve Tissue Proteins _xdrug effects |
650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xdrug effects |
650 | 0 | 4 | _aSerotonin Plasma Membrane Transport Proteins |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xpharmacology |
650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
650 | 0 | 4 |
_aSynaptosomes _xchemistry |
650 | 0 | 4 |
_aThiadiazoles _xpharmacology |
773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 55 _gno. 3 _gp. 156-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/syn.20104 _zAvailable from publisher's website |
999 |
_c15284944 _d15284944 |